Carolinas Inc - Local Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Dr. Reddys Laboratories Ltd. ADS (NY: RDY)
37.52 USD  +0.20 (+0.54%)
Official Closing Price  /  Updated: 6:40 PM EDT, May 24, 2013  /  Add to My Watchlist      
View: Quote News Research
Stories about Dr. Reddys Laboratories Ltd. ADS
 
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Lowest PEG Ratio
May 24, 2013
Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of PEG ratio. United Therapeutics (NASDAQ: UTHR ) has a PEG ratio of 0.28. United Therapeutics had $670.64... Read More
category Benzinga , Drug Manufacturers/Other Industry , UTHR , and 6 more.
from Latest Articles from Benzinga.com
US Stocks Seen Down on China Concerns
May 14, 2013
U.S. stock index futures signaled a lower open on Tuesday, as fears that China's central bank will not provide stimulus to boost its economy saw the Shanghai Composite fall to a one-week low. Read More
category Investing/Bonds , Economics , tvcodes/tvearn , and 15 more.
from CNBC.com News
Pleasant Surprises from the First Quarter
May 01, 2013
Despite dicey economic conditions, many of our holdings so far have posted remarkably strong earnings results. Read More
from Update Content Feed for Financial Content
Dr Reddys Laboratories: The Winning Streak Continues (RDY)
April 30, 2013
from Comtex SmarTrend® News Briefs
The Earnings Picture So Far
April 17, 2013
The operating performance of our holdings this quarter has been encouraging. Read More
from Update Content Feed for Financial Content
Indian Powerhouses
April 15, 2013
India’s economy, the fourth largest in the world, is expected to grow 6 percent year. But the Indian equity market has stalled. The Bombay Stock Exchange’s SENSEX Index is flat for the past 12 months,... Read More
from Update Content Feed for Financial Content
Dr Reddys Laboratories Rising Today on Above-Average Volume (RDY)
April 08, 2013
from Comtex SmarTrend® News Briefs
Dr. Reddy’s Gets Ready
April 03, 2013
This generic drug maker based in India got a big boost this week from a landmark court ruling. Read More
from Update Content Feed for Financial Content
TIP, AXHE: Big ETF Outflows
March 15, 2013
Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the iShares Barclays TIPS Bond Fund (TIP), which shed... Read More
category ETFs
from ETF Channel
Dr. Reddy's (RDY) Founder & Chairman Passes Away
March 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8188289 for the full story. Read More
from StreetInsider.com News Articles
RSI Alert For Dr. Reddy's Laboratories Ltd. (RDY)
February 26, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
category Stocks
from Market News Video
Transcept (TSPT) Notified of ANDA Filing for Generic Intermezzo by Dr. Reddy's (RDY)
February 25, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8129924 for the full story. Read More
from StreetInsider.com News Articles
If You’re Looking for Growth, Overlook India
February 20, 2013
 Read More
category NASDAQ:INDY , NYSE:INFY , NYSE:IFN , and 3 more.
from InvestorPlace - Latest Headlines
UPDATE: Citigroup Reiterates Buy Rating, Raises PT on Dr. Reddy's Laboratories After Disappointing 3Q
February 15, 2013
In a report published Friday, Citigroup reiterated its Buy rating on Dr. Reddy's Laboratories (NYSE: RDY ), and raised its price target to $39.36. Citigroup noted, “We rate DRL Buy with a Target Price... Read More
category RDY , Citigroup , Benzinga , and 3 more.
from Latest Articles from Benzinga.com
BofA/Merrill Lynch Downgrades Dr. Reddy's Laboratories (RDY) to Neutral
February 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8104936 for the full story. Read More
from StreetInsider.com News Articles
Dr. Reddys Labs (RDY) Reports Q3 EPS of $0.40
February 14, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8095002 for the full story. Read More
from StreetInsider.com News Articles
Earnings Scheduled For February 14, 2013
February 14, 2013
Alexion Pharmaceuticals (NASDAQ: ALXN ) is expected to report its Q4 earnings at $0.53 per share on revenue of $316.49 million. General Motors Company (NYSE: GM ) is estimated to report its Q4 earnings... Read More
category SPW , Earnings , Benzinga , and 38 more.
from Latest Articles from Benzinga.com
Dr. Reddy's Announces Offer for OctoPlus is Unconditional
February 12, 2013
With reference to the joint press releases of Dr. Reddy's (NYSE: RDY ) and OctoPlus (NYSE Euronext Amsterdam: OCTO), issued on 22 October 2012 and 13 December 2012 respectively, the Offeror and... Read More
category Management , Benzinga , Global , and 6 more.
from Latest Articles from Benzinga.com
Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield
February 11, 2013
Below are the top drug manufacturers-other stocks on the NYSE in terms of dividend yield. Teva Pharmaceutical Industries (NYSE: TEVA ) has a dividend yield of 2.10%. Teva's shares closed at $38.68 on... Read More
category Benzinga , Highest Dividend Yield , Drug Manufacturers/Other Industry , and 7 more.
from Latest Articles from Benzinga.com
Watch for Continued Gains in Shares of Dr Reddys Laboratories (RDY)
January 29, 2013
from Comtex SmarTrend® News Briefs
A Peek Into The Market Before The Trading Starts
January 25, 2013
Pre-open movers US stock futures are higher this morning, as investors are awaiting new home sales data. Futures for the Dow Jones Industrial Average gained 32 points to 13,813.00 and S&P 500 index... Read More
category US2561352038 , Citigroup , Benzinga , and 17 more.
from Latest Articles from Benzinga.com
Dr. Reddy's Launches Desloratadine ODT
January 25, 2013
Dr. Reddy's Laboratories (NYSE: RDY ) announced today that it has launched Desloratadine ODT (2.5 mg & 5 mg), a bioequivalent generic version of Clarinex® Reditabs® (desloratadine) in the US market on Read More
category US2561352038 , Management , Benzinga , and 5 more.
from Latest Articles from Benzinga.com
Dr Reddys Laboratories: The Winning Streak Continues (RDY)
January 22, 2013
from Comtex SmarTrend® News Briefs
Dr Reddys Laboratories: The Winning Streak Continues (RDY)
January 17, 2013
from Comtex SmarTrend® News Briefs
GLD, HGEM: Big ETF Outflows
January 11, 2013
Turning today to week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, the largest outflow was seen in the SPDR Gold Shares (GLD), which shed 3,200,000 shares, or... Read More
category ETFs
from ETF Channel
Top 4 Mid-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue
December 19, 2012
Below are the top mid-cap drug manufacturers-other stocks on the NYSE and the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Forest Laboratories (NYSE: FRX ) is $3.82 billion. Forest... Read More
category US2561352038 , Mid/Cap , Benzinga , and 10 more.
from Latest Articles from Benzinga.com
A Peek Into The Market Before The Trading Starts
December 14, 2012
Pre-open movers US stock futures are higher this morning, as investors are awaiting consumer prices and industrial production data. Futures for the Dow Jones Industrial Average surged 43 points to... Read More
category US2561352038 , Benzinga , Global , and 15 more.
from Latest Articles from Benzinga.com
Dr. Reddy's Launches Cash Offer for OctoPlus for EUR 0.52/Share
December 14, 2012
Dr. Reddy's Laboratories Limited (NYSE: RDY ) [“Dr. Reddy's”], together with its subsidiaries, launches the recommended public offer to acquire all the issued and outstanding shares of OctoPlus N.V.... Read More
category US2561352038 , Earnings , Management , and 6 more.
from Latest Articles from Benzinga.com
Credit Suisse Upgrades Dr. Reddy's Laboratories (RDY) to Outperform
December 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7945908 for the full story. Read More
from StreetInsider.com News Articles
Are Indian Stocks A Buy?
December 12, 2012
from Trefis
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here